Recombinant cytomegalovirus glycoprotein B vaccine: Rethinking the immunological basis of protection

Research output: Contribution to journalComment/debatepeer-review

19 Scopus citations
Original languageEnglish (US)
Pages (from-to)6110-6112
Number of pages3
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number24
StatePublished - Jun 12 2018

Bibliographical note

Funding Information:
The author’s research is supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health Grant R01 HD079918, and by March of Dimes Birth Defects Foundation Grant FY17-849.

Cite this